Intervention Review

Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease

  1. Paul Jones1,*,
  2. Michael Greenstone2

Editorial Group: Cochrane Airways Group

Published Online: 22 JAN 2001

Assessed as up-to-date: 26 OCT 2010

DOI: 10.1002/14651858.CD002881


How to Cite

Jones P, Greenstone M. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2001, Issue 1. Art. No.: CD002881. DOI: 10.1002/14651858.CD002881.

Author Information

  1. 1

    St George's Hospital Medical School, Cardiovascular Medicine, London, UK

  2. 2

    Castle Hill Hospital, Cottingham, North Humberside, UK

*Paul Jones, Cardiovascular Medicine, St George's Hospital Medical School, Cranmer Terrace, London, SW17 0RE, UK. pjones@sgul.ac.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 22 JAN 2001

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ragnhild Gulsvik, Ingunn Skjørten, Kenneth Undhjem, Lars Holø, Anne Frostad, Eirunn Waatevik Saure, Vasvija Lejlic, Sjur Humerfelt, Gunnar Hansen, Torgeir Bruun Wyller, Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis, The Clinical Respiratory Journal, 2013, 7, 4
  2. 2
    M. Carrera, E. Sala, B.G. Cosío, A.G.N. Agustí, Tratamiento hospitalario de los episodios de agudización de la EPOC. Una revisión basada en la evidencia, Archivos de Bronconeumología, 2005, 41, 4, 220

    CrossRef